SCHEMBL17952991

SCHEMBL17952991

CC1=Cc2c(cccc2N2c3ccccc3CCC2C)C1CC1C(C)=Cc2c1cccc2N1c2ccccc2CC1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.35
LMNA P02545 2/20 0.35
HSD17B10 Q99714 2/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
CLK1 P49759 1/20 0.35
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM1 P11229 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CHRM3 P20309 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
NOTUM Q6P988 2/20 0.33
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
OPRL1 P41146 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17169026 0.95 L3MBTL1 (0.37) LMNAPOLBL3MBTL1CHRM2CHRM4
SCHEMBL17169027 0.93 ROCK1 (0.39) ROCK1LMNAHSD17B10PKMHTT
SCHEMBL17952997 0.91 LMNA (0.31) ROCK1LMNAHSD17B10PKMHTT
SCHEMBL17952996 0.88 CHRM2 (0.34) HSD17B10HTTPOLBL3MBTL1CHRM2
SCHEMBL17952995 0.88 ROCK1 (0.35) ROCK1LMNAHSD17B10PKMHTT
SCHEMBL17952986 0.87 RXRA (0.33) PKMPOLBL3MBTL1CHRM2CHRM4
SCHEMBL17952989 0.86 CHRM2 (0.35) ROCK1POLBL3MBTL1CHRM2CHRM4
SCHEMBL17952988 0.86 ROCK1 (0.34) ROCK1LMNAHSD17B10PKMHTT
SCHEMBL17952992 0.85 ALDH1A1 (0.37) ROCK1LMNAHSD17B10PKMHTT
SCHEMBL17952994 0.85 HTR7 (0.33) POLBL3MBTL1CHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790240-B2 Ligand compound, a preparation method thereof, a transition metal compound, and a preparation method thereof LG CHEM, LTD. (KR) 2017-10-17 US disclosed
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF LG CHEM, LTD. (KR) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF CD40LG, OSTC, TNFSF10 ROCK1 3232/4885LMNA 3766/4885HSD17B10 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.